デフォルト表紙
市場調査レポート
商品コード
1762088

バイオシミラー市場分析と2034年までの予測:タイプ、製品、用途、エンドユーザー、技術、プロセス、コンポーネント、段階、サービス、デバイス

Biosimilars Market Analysis and Forecast to 2034: Type, Product, Application, End User, Technology, Process, Component, Stage, Services, Device


出版日
ページ情報
英文 390 Pages
納期
3~5営業日
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=146.89円
バイオシミラー市場分析と2034年までの予測:タイプ、製品、用途、エンドユーザー、技術、プロセス、コンポーネント、段階、サービス、デバイス
出版日: 2025年07月01日
発行: Global Insight Services
ページ情報: 英文 390 Pages
納期: 3~5営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

バイオシミラー市場は、2024年の240億米ドルから2034年までには1,177億米ドルに拡大し、約17.3%のCAGRで成長すると予測されています。バイオシミラー市場には、すでに承認されている基準製品と類似性が高く、安全性や有効性に臨床的に意味のある違いがない生物学的製剤が含まれます。この市場を牽引しているのは、生物製剤の特許切れ、費用対効果、手頃な価格のヘルスケアソリューションに対する需要の高まりです。バイオシミラー医薬品の承認をサポートするために、さまざまな地域の規制枠組みが進化しており、イノベーションと競争が促進されています。ヘルスケアシステムは、コスト圧力と先進的な治療オプションの必要性のバランスを模索しており、市場は大きく成長する見込みです。

業界の概要

バイオシミラー市場は、世界の関税、地政学的緊張、進化するサプライチェーンダイナミクスといった複雑な情勢を乗り越えています。日本と韓国は戦略的にバイオシミラー機能を強化し、イノベーションを活用して関税の影響を緩和し、外国製生物製剤への依存を減らしています。中国は、国の支援により強固な国内バイオシミラー部門を育成しており、自立に重点を置く姿勢を強めています。台湾は、バイオ医薬品製造において極めて重要である一方、米国と中国の摩擦の中で地政学的な脆弱性に直面しています。世界的に見ると、バイオシミラー市場は、生物製剤に代わる費用対効果の高い代替品と高齢化によって活況を呈しています。2035年までには、弾力性のあるサプライチェーンと戦略的提携を条件として、市場は大きく拡大する見通しです。中東紛争は主にエネルギー価格に影響を与えますが、間接的にバイオシミラーの生産コストと世界の流通物流に影響を与えます。

市場セグメンテーション
タイプ 組換えグリコシル化タンパク質、組換え非グリコシル化タンパク質、ペプチド
製品 モノクローナル抗体、インスリン、エリスロポエチン、顆粒球コロニー刺激因子、ヒト成長ホルモン、インターフェロン、不妊ホルモン
用途 がん、慢性疾患、自己免疫疾患、血液疾患、感染症、成長ホルモン欠乏症
エンドユーザー 病院、クリニック、研究機関、製薬会社、バイオテクノロジー企業
技術 組み換えDNA技術、モノクローナル抗体技術、タンパク質配列決定、バイオインフォマティクス
プロセス 上流工程、下流工程
コンポーネント 原薬、最終製剤
段階 臨床試験、前臨床試験、商業化
サービス 受託製造、受託調査、薬事コンサルティング
デバイス バイオリアクター、クロマトグラフィーシステム

市場概要:

バイオシミラー市場は、主に費用対効果の高い生物学的製剤に対するニーズの高まりと、先発生物製剤の特許切れに後押しされ、堅調な拡大を続けています。がん領域は、がん罹患率の増加と参照用生物製剤の高コストが市場を牽引しています。がん領域におけるバイオシミラーは、大幅なコスト削減と同等の有効性を提供するため、ヘルスケアプロバイダーや支払者にとって非常に魅力的です。さらに、生物学的製剤の開発・製造技術の進歩がバイオシミラーの採用を後押ししています。自己免疫疾患や糖尿病などの新たなサブセグメントは、これらの疾患の罹患率が上昇し、医師や患者の間でバイオシミラーが受け入れられつつあることから、大幅な成長が見込まれています。特に自己免疫疾患分野は、モノクローナル抗体の技術革新と次世代バイオシミラーの開発から恩恵を受けると予想され、これにより患者の予後改善と治療選択肢の拡大が期待され、市場ダイナミクスに大きな影響を与えます。

競合の概要:

バイオシミラー市場はダイナミックな市場シェア分布が特徴であり、がんの罹患率の増加と費用対効果の高い代替治療への需要から、がん領域が突出したリーダーとして台頭しています。免疫分野は、自己免疫疾患の罹患率の上昇と、それに伴う手頃な治療選択肢の必要性により、僅差で続いています。地域別では、欧州が確立された規制の枠組みと高い普及率によって市場の主導的地位を維持している一方、アジア太平洋は医療費の増加と政府の支援策に後押しされて力強い成長を遂げています。業界の主要企業は、この急成長市場でより大きなシェアを獲得するため、戦略的提携や製品の上市を通じて積極的にポートフォリオを強化しています。バイオシミラー市場の競合情勢は、特に厳格な承認プロセスが製品の安全性と有効性を保証する欧州や北米などの地域における規制の影響によって大きく形成されています。Amgen、Sandoz、Pfizerなどの企業が最前線に立ち、広範な研究能力と戦略的提携を活用して競争優位を獲得しています。今後については、いくつかの大ヒット生物製剤の特許が切れ、医療従事者や患者の間でバイオシミラーが受け入れられつつあることが追い風となり、市場は大きく成長する見通しです。しかし、知的財産権紛争や市場参入障壁などの課題は依然として残っています。しかし、バイオテクノロジーの進歩と継続的な規制当局の支援により、市場拡大の好機が生まれると期待されています。

主要動向と促進要因:

バイオシミラー市場は、ブロックバスター生物製剤の特許切れによって市場がバイオシミラー競争に開放され、力強い成長を遂げています。この動向はさらに、費用対効果の高い治療オプションが必要とされる慢性疾患の蔓延が後押ししています。政府やヘルスケアプロバイダーは、医療費削減のためにバイオシミラーの採用を積極的に推進しています。バイオシミラーの開発と製造における技術の進歩は、製品の品質を高め、市場投入までの時間を短縮しています。この進歩は、規制当局の承認を得て市場の受容性を促進する上で極めて重要です。さらに、主要製薬企業による研究開発への投資の拡大が技術革新を促進し、バイオシミラー医薬品のパイプラインの充実につながっています。市場はまた、専門知識を活用しリソースを共有するために、製薬企業間の共同研究や提携が増加していることも目の当たりにしています。こうした動向はバイオシミラーの開発と商業化を加速させ、市場の裾野を広げています。さらに、医療従事者や患者の間でバイオシミラーの認知度と受容度が高まっていることも、市場の需要を促進しています。バイオシミラーの普及が進むにつれて、ヘルスケアインフラが急速に発展している新興市場には成長機会が豊富にあり、業界各社に大きな成長の可能性をもたらしています。

抑制要因と課題:

バイオシミラー市場にはいくつかの大きな抑制要因と課題があります。主な課題は、規制が複雑で地域によってばらつきがあるため、承認が遅れ、コストが増大することです。この複雑さにより、大規模な臨床試験が必要となることが多く、メーカーの経済的負担が増しています。さらに、バイオシミラーの処方に対する医師の認識と信頼が著しく欠如しており、これがバイオシミラーの採用を妨げています。特許訴訟を含む知的財産権紛争も、市場参入と拡大の妨げとなります。さらに、上市後のバイオシミラーの安全性と有効性を監視するための強固なファーマコビジランスシステムの必要性は、ロジスティクスと財政上の課題となっています。最後に、先発バイオ医薬品に対するブランドロイヤルティが定着しているため、バイオシミラーはコスト面で有利であるにもかかわらず、市場シェアを拡大することが困難です。これらの要因が総合的に、ヘルスケア市場におけるバイオシミラーの迅速な成長と幅広い受容を妨げています。

目次

第1章 バイオシミラー市場概要

  • 調査目的
  • バイオシミラー市場の定義と調査範囲
  • レポートの制限事項
  • 調査対象年と通貨
  • 調査手法

第2章 エグゼクティブサマリー

第3章 市場に関する重要考察

第4章 バイオシミラー市場の展望

  • バイオシミラー市場のセグメンテーション
  • 市場力学
  • ポーターのファイブフォース分析
  • PESTLE分析
  • バリューチェーン分析
  • 4Pモデル
  • ANSOFFマトリックス

第5章 バイオシミラー市場戦略

  • 親市場分析
  • 需給分析
  • 消費者の購買意欲
  • ケーススタディ分析
  • 価格分析
  • 規制状況
  • サプライチェーン分析
  • 競合製品分析
  • 最近の動向

第6章 バイオシミラーの市場規模

  • バイオシミラーの市場規模:金額別
  • バイオシミラーの市場規模:数量別

第7章 バイオシミラー市場:タイプ別

  • 市場概要
  • 組換えグリコシル化タンパク質
  • 組み換え非糖化タンパク質
  • ペプチド
  • その他

第8章 バイオシミラー市場:製品別

  • 市場概要
  • モノクローナル抗体
  • インスリン
  • エリスロポエチン
  • 顆粒球コロニー刺激因子
  • ヒト成長ホルモン
  • インターフェロン
  • 不妊治療ホルモン
  • その他

第9章 バイオシミラー市場:用途別

  • 市場概要
  • がん領域
  • 慢性疾患
  • 自己免疫疾患
  • 血液疾患
  • 感染症
  • 成長ホルモン欠乏症
  • その他

第10章 バイオシミラー市場:エンドユーザー別

  • 市場概要
  • 病院
  • 診療所
  • 研究機関
  • 製薬会社
  • バイオテクノロジー企業
  • その他

第11章 バイオシミラー市場:技術別

  • 市場概要
  • 組み換えDNA技術
  • モノクローナル抗体技術
  • タンパク質配列決定
  • バイオインフォマティクス
  • その他

第12章 バイオシミラー市場:プロセス別

  • 市場概要
  • 上流工程
  • 下流工程
  • その他

第13章 バイオシミラー市場:コンポーネント別

  • 市場概要
  • 原薬(API)
  • 完成製剤
  • その他

第14章 バイオシミラー市場:段階別

  • 市場概要
  • 臨床試験
  • 前臨床試験
  • 商業化
  • その他

第15章 バイオシミラー市場:サービス別

  • 市場概要
  • 受託製造
  • 受託調査
  • 薬事コンサルティング
  • その他

第16章 バイオシミラー市場:デバイス別

  • 市場概要
  • バイオリアクター
  • クロマトグラフィーシステム
  • その他

第17章 バイオシミラー市場:地域別

  • 概要
  • 北米
    • 米国
    • カナダ
  • 欧州
    • 英国
    • ドイツ
    • フランス
    • スペイン
    • イタリア
    • オランダ
    • スウェーデン
    • スイス
    • デンマーク
    • フィンランド
    • ロシア
    • その他欧州
  • アジア太平洋
    • 中国
    • インド
    • 日本
    • 韓国
    • オーストラリア
    • シンガポール
    • インドネシア
    • 台湾
    • マレーシア
    • その他アジア太平洋
  • ラテンアメリカ
    • ブラジル
    • メキシコ
    • アルゼンチン
    • その他ラテンアメリカ
  • 中東・アフリカ
    • サウジアラビア
    • アラブ首長国連邦
    • 南アフリカ
    • その他中東・アフリカ

第18章 競合情勢

  • 概要
  • 市場シェア分析
  • 主要企業のポジショニング
  • 競合リーダーシップマッピング
  • ベンダーベンチマーキング
  • 開発戦略のベンチマーキング

第19章 企業プロファイル

  • Alvotech
  • Coherus BioSciences
  • Amgen
  • Samsung Bioepis
  • Celltrion
  • Biocon
  • Sandoz
  • Mylan
  • Fresenius Kabi
  • Stada Arzneimittel
  • Dr Reddy's Laboratories
  • Lupin
  • Hikma Pharmaceuticals
  • Apotex
  • Teva Pharmaceutical Industries
  • Zydus Cadila
  • Torrent Pharmaceuticals
  • Cadila Healthcare
  • Alkem Laboratories
  • Gedeon Richter
目次
Product Code: GIS20363

Biosimilars Market is anticipated to expand from $24.0 billion in 2024 to $117.7 billion by 2034, growing at a CAGR of approximately 17.3%. Biosimilars Market encompasses biologic medical products highly similar to already approved reference products, offering no clinically meaningful differences in safety or efficacy. This market is driven by patent expirations of biologics, cost-effectiveness, and increasing demand for affordable healthcare solutions. Regulatory frameworks in various regions are evolving to support biosimilar approvals, fostering innovation and competition. The market is poised for significant growth as healthcare systems seek to balance cost pressures with the need for advanced therapeutic options.

Industry Overview:

The biosimilars market is navigating a complex landscape of global tariffs, geopolitical tensions, and evolving supply chain dynamics. Japan and South Korea are strategically enhancing their biosimilar capabilities, leveraging innovation to mitigate tariff impacts and reduce dependency on foreign biologics. China's focus on self-reliance is intensifying, with state-backed initiatives fostering a robust domestic biosimilars sector. Taiwan, while pivotal in biopharmaceutical manufacturing, faces geopolitical vulnerabilities amidst US-China frictions. Globally, the biosimilars market is buoyant, driven by cost-effective alternatives to biologics and an aging population. By 2035, the market is poised for significant expansion, contingent on resilient supply chains and strategic alliances. Middle East conflicts, while primarily affecting energy prices, indirectly influence biosimilar production costs and distribution logistics worldwide.

Market Segmentation
TypeRecombinant Glycosylated Proteins, Recombinant Non-Glycosylated Proteins, Peptides
ProductMonoclonal Antibodies, Insulin, Erythropoietin, Granulocyte Colony-Stimulating Factor, Human Growth Hormone, Interferons, Fertility Hormones
ApplicationOncology, Chronic Diseases, Autoimmune Diseases, Blood Disorders, Infectious Diseases, Growth Hormone Deficiency
End UserHospitals, Clinics, Research Institutes, Pharmaceutical Companies, Biotechnology Firms
TechnologyRecombinant DNA Technology, Monoclonal Antibody Technology, Protein Sequencing, Bioinformatics
ProcessUpstream Processing, Downstream Processing
ComponentActive Pharmaceutical Ingredients (API), Finished Dosage Formulations
StageClinical Trials, Preclinical Studies, Commercialization
ServicesContract Manufacturing, Contract Research, Regulatory Consulting
DeviceBioreactors, Chromatography Systems

Market Overview:

The Biosimilars Market is experiencing robust expansion, primarily fueled by the rising need for cost-effective biologic therapies and the expiration of patents for original biologics. The oncology segment leads the market, driven by the increasing prevalence of cancer and the high cost of reference biologics. Biosimilars in oncology offer significant cost savings and comparable efficacy, making them highly attractive to healthcare providers and payers. Furthermore, advancements in biologic drug development and manufacturing technologies enhance their adoption. Emerging sub-segments, such as autoimmune diseases and diabetes, are poised for substantial growth due to the rising incidence of these conditions and the growing acceptance of biosimilars among physicians and patients. The autoimmune segment, in particular, is expected to benefit from ongoing innovations in monoclonal antibodies and the development of next-generation biosimilars, which promise improved patient outcomes and expanded therapeutic options, thereby significantly impacting market dynamics.

Geographical Overview:

The biosimilars market is witnessing remarkable growth, with regional dynamics playing a pivotal role. In North America, the market is expanding due to a robust regulatory framework and increasing healthcare expenditure. The United States, a key player, is driving growth through strategic collaborations and a focus on reducing healthcare costs. Europe stands as a leader in the biosimilars market, propelled by supportive government policies and a strong emphasis on cost-effective healthcare solutions. The region's well-established pharmaceutical industry and high acceptance rates among healthcare professionals further contribute to its dominance. Germany and the United Kingdom are at the forefront. In Asia Pacific, the biosimilars market is experiencing rapid expansion. This growth is driven by a surge in chronic diseases and an aging population. Countries like China and India are investing heavily in biosimilar development and manufacturing. Their large patient pools and increasing healthcare access further bolster market potential. Latin America is an emerging market for biosimilars, with growing awareness and acceptance among healthcare providers. Brazil and Mexico are leading the way, focusing on regulatory improvements and cost-saving initiatives. The region's potential is significant, given its evolving healthcare landscape. The Middle East & Africa region is gradually recognizing the benefits of biosimilars. The market here is driven by the need to improve healthcare affordability and accessibility. Countries like Saudi Arabia and South Africa are making strides in adopting biosimilars to enhance healthcare outcomes and economic efficiency.

Competition Overview:

The biosimilars market is characterized by a dynamic distribution of market share, with the oncology segment emerging as a prominent leader due to the increasing prevalence of cancer and the demand for cost-effective treatment alternatives. The immunology segment follows closely, driven by the rising incidence of autoimmune diseases and the subsequent need for affordable therapeutic options. Geographically, Europe maintains a leadership position in the market due to its well-established regulatory framework and high adoption rates, while the Asia-Pacific region is witnessing robust growth fueled by increasing healthcare expenditure and supportive government initiatives. Key industry players are actively enhancing their portfolios through strategic collaborations and product launches to capture a larger share of this burgeoning market. The competitive landscape of the biosimilars market is shaped significantly by regulatory influences, particularly in regions like Europe and North America, where stringent approval processes ensure product safety and efficacy. Companies such as Amgen, Sandoz, and Pfizer are at the forefront, leveraging their extensive research capabilities and strategic alliances to gain competitive advantage. Looking ahead, the market is poised for substantial growth, driven by the expiration of patents for several blockbuster biologics and the increasing acceptance of biosimilars among healthcare providers and patients. However, challenges such as intellectual property disputes and market entry barriers persist. Nonetheless, advancements in biotechnology and ongoing regulatory support are expected to create lucrative opportunities for market expansion.

Recent Developments:

The biosimilars market has experienced notable developments in recent months. Amgen announced a strategic partnership with a leading European pharmaceutical company to co-develop and commercialize a new biosimilar targeting autoimmune diseases, aiming to expand their presence in the European market. In regulatory news, the U.S. FDA approved a groundbreaking biosimilar for treating cancer, marking a significant milestone in oncology therapeutics and potentially reducing treatment costs. Pfizer and Biocon Biologics entered a joint venture to enhance their biosimilars portfolio, focusing on emerging markets in Asia and Africa, which are projected to see substantial growth in demand. Market analysts reported a surge in biosimilars adoption in the European Union, driven by favorable regulatory policies and increased physician acceptance, which is expected to boost market growth. Lastly, a prominent South Korean biosimilar manufacturer announced a major investment to expand its production facilities, aiming to meet the growing global demand for cost-effective biologic treatments. These developments underscore the dynamic nature of the biosimilars market, highlighting opportunities for growth and innovation.

Key Companies:

Alvotech, Coherus Bio Sciences, Amgen, Samsung Bioepis, Celltrion, Biocon, Sandoz, Mylan, Fresenius Kabi, Stada Arzneimittel, Dr Reddy's Laboratories, Lupin, Hikma Pharmaceuticals, Apotex, Teva Pharmaceutical Industries, Zydus Cadila, Torrent Pharmaceuticals, Cadila Healthcare, Alkem Laboratories, Gedeon Richter

Key Trends and Drivers:

The biosimilars market is experiencing robust growth, propelled by the expiration of patents for blockbuster biologics, which opens the market to biosimilar competition. This trend is further driven by the increasing prevalence of chronic diseases, which necessitates cost-effective treatment options. Governments and healthcare providers are actively promoting the adoption of biosimilars to reduce healthcare expenditure. Technological advancements in the development and manufacturing of biosimilars are enhancing product quality and reducing time-to-market. This progress is crucial in gaining regulatory approval and fostering market acceptance. Additionally, the growing investment in research and development by key pharmaceutical companies is fueling innovation, leading to a broader pipeline of biosimilar products. The market is also witnessing increased collaborations and partnerships among pharmaceutical companies to leverage expertise and share resources. This trend is accelerating the development and commercialization of biosimilars, thus expanding market reach. Moreover, the rising awareness and acceptance of biosimilars among healthcare professionals and patients are driving market demand. As biosimilars continue to gain traction, opportunities abound in emerging markets where healthcare infrastructure is rapidly evolving, presenting significant growth potential for industry players.

Restraints and Challenges:

The biosimilars market encounters several significant restraints and challenges. A primary challenge is the regulatory complexity and variability across regions, which can delay approvals and increase costs. This complexity often necessitates extensive clinical trials, adding to the financial burden on manufacturers. Furthermore, there is a notable lack of physician awareness and confidence in prescribing biosimilars, which hampers their adoption. Intellectual property disputes, including patent litigations, can also obstruct market entry and expansion. Additionally, the need for robust pharmacovigilance systems to monitor biosimilar safety and efficacy post-launch poses logistical and financial challenges. Lastly, the entrenched brand loyalty to original biologics makes it difficult for biosimilars to gain market share, despite their cost advantages. These factors collectively impede the swift growth and broader acceptance of biosimilars in the healthcare market.

Research Scope:

  • Estimates and forecasts the overall market size across type, application, and region.
  • Provides detailed information and key takeaways on qualitative and quantitative trends, dynamics, business framework, competitive landscape, and company profiling.
  • Identifies factors influencing market growth and challenges, opportunities, drivers, and restraints.
  • Identifies factors that could limit company participation in international markets to help calibrate market share expectations and growth rates.
  • Evaluates key development strategies like acquisitions, product launches, mergers, collaborations, business expansions, agreements, partnerships, and R&D activities.
  • Analyzes smaller market segments strategically, focusing on their potential, growth patterns, and impact on the overall market.
  • Outlines the competitive landscape, assessing business and corporate strategies to monitor and dissect competitive advancements.

Our research scope provides comprehensive market data, insights, and analysis across a variety of critical areas. We cover Local Market Analysis, assessing consumer demographics, purchasing behaviors, and market size within specific regions to identify growth opportunities. Our Local Competition Review offers a detailed evaluation of competitors, including their strengths, weaknesses, and market positioning. We also conduct Local Regulatory Reviews to ensure businesses comply with relevant laws and regulations. Industry Analysis provides an in-depth look at market dynamics, key players, and trends. Additionally, we offer Cross-Segmental Analysis to identify synergies between different market segments, as well as Production-Consumption and Demand-Supply Analysis to optimize supply chain efficiency. Our Import-Export Analysis helps businesses navigate global trade environments by evaluating trade flows and policies. These insights empower clients to make informed strategic decisions, mitigate risks, and capitalize on market opportunities.

TABLE OF CONTENTS

1: Biosimilars Market Overview

  • 1.1 Objectives of the Study
  • 1.2 Biosimilars Market Definition and Scope of the Report
  • 1.3 Report Limitations
  • 1.4 Years & Currency Considered in the Study
  • 1.5 Research Methodologies
    • 1.5.1 Secondary Research
    • 1.5.2 Primary Research
    • 1.5.3 Market Size Estimation: Top-Down Approach
    • 1.5.4 Market Size Estimation: Bottom-Up Approach
    • 1.5.5 Data Triangulation and Validation

2: Executive Summary

  • 2.1 Summary
  • 2.2 Key Opinion Leaders
  • 2.3 Key Highlights of the Market, by Type
  • 2.4 Key Highlights of the Market, by Product
  • 2.5 Key Highlights of the Market, by Application
  • 2.6 Key Highlights of the Market, by End User
  • 2.7 Key Highlights of the Market, by Technology
  • 2.8 Key Highlights of the Market, by Process
  • 2.9 Key Highlights of the Market, by Component
  • 2.10 Key Highlights of the Market, by Stage
  • 2.11 Key Highlights of the Market, by Services
  • 2.12 Key Highlights of the Market, by Device
  • 2.13 Key Highlights of the Market, by North America
  • 2.14 Key Highlights of the Market, by Europe
  • 2.15 Key Highlights of the Market, by Asia-Pacific
  • 2.16 Key Highlights of the Market, by Latin America
  • 2.17 Key Highlights of the Market, by Middle East
  • 2.18 Key Highlights of the Market, by Africa

3: Premium Insights on the Market

  • 3.1 Market Attractiveness Analysis, by Region
  • 3.2 Market Attractiveness Analysis, by Type
  • 3.3 Market Attractiveness Analysis, by Product
  • 3.4 Market Attractiveness Analysis, by Application
  • 3.5 Market Attractiveness Analysis, by End User
  • 3.6 Market Attractiveness Analysis, by Technology
  • 3.7 Market Attractiveness Analysis, by Process
  • 3.8 Market Attractiveness Analysis, by Component
  • 3.9 Market Attractiveness Analysis, by Stage
  • 3.10 Market Attractiveness Analysis, by Services
  • 3.11 Market Attractiveness Analysis, by Device
  • 3.12 Market Attractiveness Analysis, by North America
  • 3.13 Market Attractiveness Analysis, by Europe
  • 3.14 Market Attractiveness Analysis, by Asia-Pacific
  • 3.15 Market Attractiveness Analysis, by Latin America
  • 3.16 Market Attractiveness Analysis, by Middle East
  • 3.17 Market Attractiveness Analysis, by Africa

4: Biosimilars Market Outlook

  • 4.1 Biosimilars Market Segmentation
  • 4.2 Market Dynamics
    • 4.2.1 Market Drivers
    • 4.2.2 Market Trends
    • 4.2.3 Market Restraints
    • 4.2.4 Market Opportunities
  • 4.3 Porters Five Forces Analysis
    • 4.3.1 Threat of New Entrants
    • 4.3.2 Threat of Substitutes
    • 4.3.3 Bargaining Power of Buyers
    • 4.3.4 Bargaining Power of Supplier
    • 4.3.5 Competitive Rivalry
  • 4.4 PESTLE Analysis
  • 4.5 Value Chain Analysis
  • 4.6 4Ps Model
  • 4.7 ANSOFF Matrix

5: Biosimilars Market Strategy

  • 5.1 Parent Market Analysis
  • 5.2 Supply-Demand Analysis
  • 5.3 Consumer Buying Interest
  • 5.4 Case Study Analysis
  • 5.5 Pricing Analysis
  • 5.6 Regulatory Landscape
  • 5.7 Supply Chain Analysis
  • 5.8 Competition Product Analysis
  • 5.9 Recent Developments

6: Biosimilars Market Size

  • 6.1 Biosimilars Market Size, by Value
  • 6.2 Biosimilars Market Size, by Volume

7: Biosimilars Market, by Type

  • 7.1 Market Overview
  • 7.2 Recombinant Glycosylated Proteins
    • 7.2.1 Key Market Trends & Opportunity Analysis
    • 7.2.2 Market Size and Forecast, by Region
  • 7.3 Recombinant Non-Glycosylated Proteins
    • 7.3.1 Key Market Trends & Opportunity Analysis
    • 7.3.2 Market Size and Forecast, by Region
  • 7.4 Peptides
    • 7.4.1 Key Market Trends & Opportunity Analysis
    • 7.4.2 Market Size and Forecast, by Region
  • 7.5 Others
    • 7.5.1 Key Market Trends & Opportunity Analysis
    • 7.5.2 Market Size and Forecast, by Region

8: Biosimilars Market, by Product

  • 8.1 Market Overview
  • 8.2 Monoclonal Antibodies
    • 8.2.1 Key Market Trends & Opportunity Analysis
    • 8.2.2 Market Size and Forecast, by Region
  • 8.3 Insulin
    • 8.3.1 Key Market Trends & Opportunity Analysis
    • 8.3.2 Market Size and Forecast, by Region
  • 8.4 Erythropoietin
    • 8.4.1 Key Market Trends & Opportunity Analysis
    • 8.4.2 Market Size and Forecast, by Region
  • 8.5 Granulocyte Colony-Stimulating Factor
    • 8.5.1 Key Market Trends & Opportunity Analysis
    • 8.5.2 Market Size and Forecast, by Region
  • 8.6 Human Growth Hormone
    • 8.6.1 Key Market Trends & Opportunity Analysis
    • 8.6.2 Market Size and Forecast, by Region
  • 8.7 Interferons
    • 8.7.1 Key Market Trends & Opportunity Analysis
    • 8.7.2 Market Size and Forecast, by Region
  • 8.8 Fertility Hormones
    • 8.8.1 Key Market Trends & Opportunity Analysis
    • 8.8.2 Market Size and Forecast, by Region
  • 8.9 Others
    • 8.9.1 Key Market Trends & Opportunity Analysis
    • 8.9.2 Market Size and Forecast, by Region

9: Biosimilars Market, by Application

  • 9.1 Market Overview
  • 9.2 Oncology
    • 9.2.1 Key Market Trends & Opportunity Analysis
    • 9.2.2 Market Size and Forecast, by Region
  • 9.3 Chronic Diseases
    • 9.3.1 Key Market Trends & Opportunity Analysis
    • 9.3.2 Market Size and Forecast, by Region
  • 9.4 Autoimmune Diseases
    • 9.4.1 Key Market Trends & Opportunity Analysis
    • 9.4.2 Market Size and Forecast, by Region
  • 9.5 Blood Disorders
    • 9.5.1 Key Market Trends & Opportunity Analysis
    • 9.5.2 Market Size and Forecast, by Region
  • 9.6 Infectious Diseases
    • 9.6.1 Key Market Trends & Opportunity Analysis
    • 9.6.2 Market Size and Forecast, by Region
  • 9.7 Growth Hormone Deficiency
    • 9.7.1 Key Market Trends & Opportunity Analysis
    • 9.7.2 Market Size and Forecast, by Region
  • 9.8 Others
    • 9.8.1 Key Market Trends & Opportunity Analysis
    • 9.8.2 Market Size and Forecast, by Region

10: Biosimilars Market, by End User

  • 10.1 Market Overview
  • 10.2 Hospitals
    • 10.2.1 Key Market Trends & Opportunity Analysis
    • 10.2.2 Market Size and Forecast, by Region
  • 10.3 Clinics
    • 10.3.1 Key Market Trends & Opportunity Analysis
    • 10.3.2 Market Size and Forecast, by Region
  • 10.4 Research Institutes
    • 10.4.1 Key Market Trends & Opportunity Analysis
    • 10.4.2 Market Size and Forecast, by Region
  • 10.5 Pharmaceutical Companies
    • 10.5.1 Key Market Trends & Opportunity Analysis
    • 10.5.2 Market Size and Forecast, by Region
  • 10.6 Biotechnology Firms
    • 10.6.1 Key Market Trends & Opportunity Analysis
    • 10.6.2 Market Size and Forecast, by Region
  • 10.7 Others
    • 10.7.1 Key Market Trends & Opportunity Analysis
    • 10.7.2 Market Size and Forecast, by Region

11: Biosimilars Market, by Technology

  • 11.1 Market Overview
  • 11.2 Recombinant DNA Technology
    • 11.2.1 Key Market Trends & Opportunity Analysis
    • 11.2.2 Market Size and Forecast, by Region
  • 11.3 Monoclonal Antibody Technology
    • 11.3.1 Key Market Trends & Opportunity Analysis
    • 11.3.2 Market Size and Forecast, by Region
  • 11.4 Protein Sequencing
    • 11.4.1 Key Market Trends & Opportunity Analysis
    • 11.4.2 Market Size and Forecast, by Region
  • 11.5 Bioinformatics
    • 11.5.1 Key Market Trends & Opportunity Analysis
    • 11.5.2 Market Size and Forecast, by Region
  • 11.6 Others
    • 11.6.1 Key Market Trends & Opportunity Analysis
    • 11.6.2 Market Size and Forecast, by Region

12: Biosimilars Market, by Process

  • 12.1 Market Overview
  • 12.2 Upstream Processing
    • 12.2.1 Key Market Trends & Opportunity Analysis
    • 12.2.2 Market Size and Forecast, by Region
  • 12.3 Downstream Processing
    • 12.3.1 Key Market Trends & Opportunity Analysis
    • 12.3.2 Market Size and Forecast, by Region
  • 12.4 Others
    • 12.4.1 Key Market Trends & Opportunity Analysis
    • 12.4.2 Market Size and Forecast, by Region

13: Biosimilars Market, by Component

  • 13.1 Market Overview
  • 13.2 Active Pharmaceutical Ingredients (API)
    • 13.2.1 Key Market Trends & Opportunity Analysis
    • 13.2.2 Market Size and Forecast, by Region
  • 13.3 Finished Dosage Formulations
    • 13.3.1 Key Market Trends & Opportunity Analysis
    • 13.3.2 Market Size and Forecast, by Region
  • 13.4 Others
    • 13.4.1 Key Market Trends & Opportunity Analysis
    • 13.4.2 Market Size and Forecast, by Region

14: Biosimilars Market, by Stage

  • 14.1 Market Overview
  • 14.2 Clinical Trials
    • 14.2.1 Key Market Trends & Opportunity Analysis
    • 14.2.2 Market Size and Forecast, by Region
  • 14.3 Preclinical Studies
    • 14.3.1 Key Market Trends & Opportunity Analysis
    • 14.3.2 Market Size and Forecast, by Region
  • 14.4 Commercialization
    • 14.4.1 Key Market Trends & Opportunity Analysis
    • 14.4.2 Market Size and Forecast, by Region
  • 14.5 Others
    • 14.5.1 Key Market Trends & Opportunity Analysis
    • 14.5.2 Market Size and Forecast, by Region

15: Biosimilars Market, by Services

  • 15.1 Market Overview
  • 15.2 Contract Manufacturing
    • 15.2.1 Key Market Trends & Opportunity Analysis
    • 15.2.2 Market Size and Forecast, by Region
  • 15.3 Contract Research
    • 15.3.1 Key Market Trends & Opportunity Analysis
    • 15.3.2 Market Size and Forecast, by Region
  • 15.4 Regulatory Consulting
    • 15.4.1 Key Market Trends & Opportunity Analysis
    • 15.4.2 Market Size and Forecast, by Region
  • 15.5 Others
    • 15.5.1 Key Market Trends & Opportunity Analysis
    • 15.5.2 Market Size and Forecast, by Region

16: Biosimilars Market, by Device

  • 16.1 Market Overview
  • 16.2 Bioreactors
    • 16.2.1 Key Market Trends & Opportunity Analysis
    • 16.2.2 Market Size and Forecast, by Region
  • 16.3 Chromatography Systems
    • 16.3.1 Key Market Trends & Opportunity Analysis
    • 16.3.2 Market Size and Forecast, by Region
  • 16.4 Others
    • 16.4.1 Key Market Trends & Opportunity Analysis
    • 16.4.2 Market Size and Forecast, by Region

17: Biosimilars Market, by Region

  • 17.1 Overview
  • 17.2 North America
    • 17.2.1 Key Market Trends and Opportunities
    • 17.2.2 North America Market Size and Forecast, by Type
    • 17.2.3 North America Market Size and Forecast, by Product
    • 17.2.4 North America Market Size and Forecast, by Application
    • 17.2.5 North America Market Size and Forecast, by End User
    • 17.2.6 North America Market Size and Forecast, by Technology
    • 17.2.7 North America Market Size and Forecast, by Process
    • 17.2.8 North America Market Size and Forecast, by Component
    • 17.2.9 North America Market Size and Forecast, by Stage
    • 17.2.10 North America Market Size and Forecast, by Services
    • 17.2.11 North America Market Size and Forecast, by Device
    • 17.2.12 North America Market Size and Forecast, by Country
    • 17.2.13 United States
      • 17.2.9.1 United States Market Size and Forecast, by Type
      • 17.2.9.2 United States Market Size and Forecast, by Product
      • 17.2.9.3 United States Market Size and Forecast, by Application
      • 17.2.9.4 United States Market Size and Forecast, by End User
      • 17.2.9.5 United States Market Size and Forecast, by Technology
      • 17.2.9.6 United States Market Size and Forecast, by Process
      • 17.2.9.7 United States Market Size and Forecast, by Component
      • 17.2.9.8 United States Market Size and Forecast, by Stage
      • 17.2.9.9 United States Market Size and Forecast, by Services
      • 17.2.9.10 United States Market Size and Forecast, by Device
      • 17.2.9.11 Local Competition Analysis
      • 17.2.9.12 Local Market Analysis
    • 17.2.1 Canada
      • 17.2.10.1 Canada Market Size and Forecast, by Type
      • 17.2.10.2 Canada Market Size and Forecast, by Product
      • 17.2.10.3 Canada Market Size and Forecast, by Application
      • 17.2.10.4 Canada Market Size and Forecast, by End User
      • 17.2.10.5 Canada Market Size and Forecast, by Technology
      • 17.2.10.6 Canada Market Size and Forecast, by Process
      • 17.2.10.7 Canada Market Size and Forecast, by Component
      • 17.2.10.8 Canada Market Size and Forecast, by Stage
      • 17.2.10.9 Canada Market Size and Forecast, by Services
      • 17.2.10.10 Canada Market Size and Forecast, by Device
      • 17.2.10.11 Local Competition Analysis
      • 17.2.10.12 Local Market Analysis
  • 17.1 Europe
    • 17.3.1 Key Market Trends and Opportunities
    • 17.3.2 Europe Market Size and Forecast, by Type
    • 17.3.3 Europe Market Size and Forecast, by Product
    • 17.3.4 Europe Market Size and Forecast, by Application
    • 17.3.5 Europe Market Size and Forecast, by End User
    • 17.3.6 Europe Market Size and Forecast, by Technology
    • 17.3.7 Europe Market Size and Forecast, by Process
    • 17.3.8 Europe Market Size and Forecast, by Component
    • 17.3.9 Europe Market Size and Forecast, by Stage
    • 17.3.10 Europe Market Size and Forecast, by Services
    • 17.3.11 Europe Market Size and Forecast, by Device
    • 17.3.12 Europe Market Size and Forecast, by Country
    • 17.3.13 United Kingdom
      • 17.3.9.1 United Kingdom Market Size and Forecast, by Type
      • 17.3.9.2 United Kingdom Market Size and Forecast, by Product
      • 17.3.9.3 United Kingdom Market Size and Forecast, by Application
      • 17.3.9.4 United Kingdom Market Size and Forecast, by End User
      • 17.3.9.5 United Kingdom Market Size and Forecast, by Technology
      • 17.3.9.6 United Kingdom Market Size and Forecast, by Process
      • 17.3.9.7 United Kingdom Market Size and Forecast, by Component
      • 17.3.9.8 United Kingdom Market Size and Forecast, by Stage
      • 17.3.9.9 United Kingdom Market Size and Forecast, by Services
      • 17.3.9.10 United Kingdom Market Size and Forecast, by Device
      • 17.3.9.11 Local Competition Analysis
      • 17.3.9.12 Local Market Analysis
    • 17.3.1 Germany
      • 17.3.10.1 Germany Market Size and Forecast, by Type
      • 17.3.10.2 Germany Market Size and Forecast, by Product
      • 17.3.10.3 Germany Market Size and Forecast, by Application
      • 17.3.10.4 Germany Market Size and Forecast, by End User
      • 17.3.10.5 Germany Market Size and Forecast, by Technology
      • 17.3.10.6 Germany Market Size and Forecast, by Process
      • 17.3.10.7 Germany Market Size and Forecast, by Component
      • 17.3.10.8 Germany Market Size and Forecast, by Stage
      • 17.3.10.9 Germany Market Size and Forecast, by Services
      • 17.3.10.10 Germany Market Size and Forecast, by Device
      • 17.3.10.11 Local Competition Analysis
      • 17.3.10.12 Local Market Analysis
    • 17.3.1 France
      • 17.3.11.1 France Market Size and Forecast, by Type
      • 17.3.11.2 France Market Size and Forecast, by Product
      • 17.3.11.3 France Market Size and Forecast, by Application
      • 17.3.11.4 France Market Size and Forecast, by End User
      • 17.3.11.5 France Market Size and Forecast, by Technology
      • 17.3.11.6 France Market Size and Forecast, by Process
      • 17.3.11.7 France Market Size and Forecast, by Component
      • 17.3.11.8 France Market Size and Forecast, by Stage
      • 17.3.11.9 France Market Size and Forecast, by Services
      • 17.3.11.10 France Market Size and Forecast, by Device
      • 17.3.11.11 Local Competition Analysis
      • 17.3.11.12 Local Market Analysis
    • 17.3.1 Spain
      • 17.3.12.1 Spain Market Size and Forecast, by Type
      • 17.3.12.2 Spain Market Size and Forecast, by Product
      • 17.3.12.3 Spain Market Size and Forecast, by Application
      • 17.3.12.4 Spain Market Size and Forecast, by End User
      • 17.3.12.5 Spain Market Size and Forecast, by Technology
      • 17.3.12.6 Spain Market Size and Forecast, by Process
      • 17.3.12.7 Spain Market Size and Forecast, by Component
      • 17.3.12.8 Spain Market Size and Forecast, by Stage
      • 17.3.12.9 Spain Market Size and Forecast, by Services
      • 17.3.12.10 Spain Market Size and Forecast, by Device
      • 17.3.12.11 Local Competition Analysis
      • 17.3.12.12 Local Market Analysis
    • 17.3.1 Italy
      • 17.3.13.1 Italy Market Size and Forecast, by Type
      • 17.3.13.2 Italy Market Size and Forecast, by Product
      • 17.3.13.3 Italy Market Size and Forecast, by Application
      • 17.3.13.4 Italy Market Size and Forecast, by End User
      • 17.3.13.5 Italy Market Size and Forecast, by Technology
      • 17.3.13.6 Italy Market Size and Forecast, by Process
      • 17.3.13.7 Italy Market Size and Forecast, by Component
      • 17.3.13.8 Italy Market Size and Forecast, by Stage
      • 17.3.13.9 Italy Market Size and Forecast, by Services
      • 17.3.13.10 Italy Market Size and Forecast, by Device
      • 17.3.13.11 Local Competition Analysis
      • 17.3.13.12 Local Market Analysis
    • 17.3.1 Netherlands
      • 17.3.14.1 Netherlands Market Size and Forecast, by Type
      • 17.3.14.2 Netherlands Market Size and Forecast, by Product
      • 17.3.14.3 Netherlands Market Size and Forecast, by Application
      • 17.3.14.4 Netherlands Market Size and Forecast, by End User
      • 17.3.14.5 Netherlands Market Size and Forecast, by Technology
      • 17.3.14.6 Netherlands Market Size and Forecast, by Process
      • 17.3.14.7 Netherlands Market Size and Forecast, by Component
      • 17.3.14.8 Netherlands Market Size and Forecast, by Stage
      • 17.3.14.9 Netherlands Market Size and Forecast, by Services
      • 17.3.14.10 Netherlands Market Size and Forecast, by Device
      • 17.3.14.11 Local Competition Analysis
      • 17.3.14.12 Local Market Analysis
    • 17.3.1 Sweden
      • 17.3.15.1 Sweden Market Size and Forecast, by Type
      • 17.3.15.2 Sweden Market Size and Forecast, by Product
      • 17.3.15.3 Sweden Market Size and Forecast, by Application
      • 17.3.15.4 Sweden Market Size and Forecast, by End User
      • 17.3.15.5 Sweden Market Size and Forecast, by Technology
      • 17.3.15.6 Sweden Market Size and Forecast, by Process
      • 17.3.15.7 Sweden Market Size and Forecast, by Component
      • 17.3.15.8 Sweden Market Size and Forecast, by Stage
      • 17.3.15.9 Sweden Market Size and Forecast, by Services
      • 17.3.15.10 Sweden Market Size and Forecast, by Device
      • 17.3.15.11 Local Competition Analysis
      • 17.3.15.12 Local Market Analysis
    • 17.3.1 Switzerland
      • 17.3.16.1 Switzerland Market Size and Forecast, by Type
      • 17.3.16.2 Switzerland Market Size and Forecast, by Product
      • 17.3.16.3 Switzerland Market Size and Forecast, by Application
      • 17.3.16.4 Switzerland Market Size and Forecast, by End User
      • 17.3.16.5 Switzerland Market Size and Forecast, by Technology
      • 17.3.16.6 Switzerland Market Size and Forecast, by Process
      • 17.3.16.7 Switzerland Market Size and Forecast, by Component
      • 17.3.16.8 Switzerland Market Size and Forecast, by Stage
      • 17.3.16.9 Switzerland Market Size and Forecast, by Services
      • 17.3.16.10 Switzerland Market Size and Forecast, by Device
      • 17.3.16.11 Local Competition Analysis
      • 17.3.16.12 Local Market Analysis
    • 17.3.1 Denmark
      • 17.3.17.1 Denmark Market Size and Forecast, by Type
      • 17.3.17.2 Denmark Market Size and Forecast, by Product
      • 17.3.17.3 Denmark Market Size and Forecast, by Application
      • 17.3.17.4 Denmark Market Size and Forecast, by End User
      • 17.3.17.5 Denmark Market Size and Forecast, by Technology
      • 17.3.17.6 Denmark Market Size and Forecast, by Process
      • 17.3.17.7 Denmark Market Size and Forecast, by Component
      • 17.3.17.8 Denmark Market Size and Forecast, by Stage
      • 17.3.17.9 Denmark Market Size and Forecast, by Services
      • 17.3.17.10 Denmark Market Size and Forecast, by Device
      • 17.3.17.11 Local Competition Analysis
      • 17.3.17.12 Local Market Analysis
    • 17.3.1 Finland
      • 17.3.18.1 Finland Market Size and Forecast, by Type
      • 17.3.18.2 Finland Market Size and Forecast, by Product
      • 17.3.18.3 Finland Market Size and Forecast, by Application
      • 17.3.18.4 Finland Market Size and Forecast, by End User
      • 17.3.18.5 Finland Market Size and Forecast, by Technology
      • 17.3.18.6 Finland Market Size and Forecast, by Process
      • 17.3.18.7 Finland Market Size and Forecast, by Component
      • 17.3.18.8 Finland Market Size and Forecast, by Stage
      • 17.3.18.9 Finland Market Size and Forecast, by Services
      • 17.3.18.10 Finland Market Size and Forecast, by Device
      • 17.3.18.11 Local Competition Analysis
      • 17.3.18.12 Local Market Analysis
    • 17.3.1 Russia
      • 17.3.19.1 Russia Market Size and Forecast, by Type
      • 17.3.19.2 Russia Market Size and Forecast, by Product
      • 17.3.19.3 Russia Market Size and Forecast, by Application
      • 17.3.19.4 Russia Market Size and Forecast, by End User
      • 17.3.19.5 Russia Market Size and Forecast, by Technology
      • 17.3.19.6 Russia Market Size and Forecast, by Process
      • 17.3.19.7 Russia Market Size and Forecast, by Component
      • 17.3.19.8 Russia Market Size and Forecast, by Stage
      • 17.3.19.9 Russia Market Size and Forecast, by Services
      • 17.3.19.10 Russia Market Size and Forecast, by Device
      • 17.3.19.11 Local Competition Analysis
      • 17.3.19.12 Local Market Analysis
    • 17.3.1 Rest of Europe
      • 17.3.20.1 Rest of Europe Market Size and Forecast, by Type
      • 17.3.20.2 Rest of Europe Market Size and Forecast, by Product
      • 17.3.20.3 Rest of Europe Market Size and Forecast, by Application
      • 17.3.20.4 Rest of Europe Market Size and Forecast, by End User
      • 17.3.20.5 Rest of Europe Market Size and Forecast, by Technology
      • 17.3.20.6 Rest of Europe Market Size and Forecast, by Process
      • 17.3.20.7 Rest of Europe Market Size and Forecast, by Component
      • 17.3.20.8 Rest of Europe Market Size and Forecast, by Stage
      • 17.3.20.9 Rest of Europe Market Size and Forecast, by Services
      • 17.3.20.10 Rest of Europe Market Size and Forecast, by Device
      • 17.3.20.11 Local Competition Analysis
      • 17.3.20.12 Local Market Analysis
  • 17.1 Asia-Pacific
    • 17.4.1 Key Market Trends and Opportunities
    • 17.4.2 Asia-Pacific Market Size and Forecast, by Type
    • 17.4.3 Asia-Pacific Market Size and Forecast, by Product
    • 17.4.4 Asia-Pacific Market Size and Forecast, by Application
    • 17.4.5 Asia-Pacific Market Size and Forecast, by End User
    • 17.4.6 Asia-Pacific Market Size and Forecast, by Technology
    • 17.4.7 Asia-Pacific Market Size and Forecast, by Process
    • 17.4.8 Asia-Pacific Market Size and Forecast, by Component
    • 17.4.9 Asia-Pacific Market Size and Forecast, by Stage
    • 17.4.10 Asia-Pacific Market Size and Forecast, by Services
    • 17.4.11 Asia-Pacific Market Size and Forecast, by Device
    • 17.4.12 Asia-Pacific Market Size and Forecast, by Country
    • 17.4.13 China
      • 17.4.9.1 China Market Size and Forecast, by Type
      • 17.4.9.2 China Market Size and Forecast, by Product
      • 17.4.9.3 China Market Size and Forecast, by Application
      • 17.4.9.4 China Market Size and Forecast, by End User
      • 17.4.9.5 China Market Size and Forecast, by Technology
      • 17.4.9.6 China Market Size and Forecast, by Process
      • 17.4.9.7 China Market Size and Forecast, by Component
      • 17.4.9.8 China Market Size and Forecast, by Stage
      • 17.4.9.9 China Market Size and Forecast, by Services
      • 17.4.9.10 China Market Size and Forecast, by Device
      • 17.4.9.11 Local Competition Analysis
      • 17.4.9.12 Local Market Analysis
    • 17.4.1 India
      • 17.4.10.1 India Market Size and Forecast, by Type
      • 17.4.10.2 India Market Size and Forecast, by Product
      • 17.4.10.3 India Market Size and Forecast, by Application
      • 17.4.10.4 India Market Size and Forecast, by End User
      • 17.4.10.5 India Market Size and Forecast, by Technology
      • 17.4.10.6 India Market Size and Forecast, by Process
      • 17.4.10.7 India Market Size and Forecast, by Component
      • 17.4.10.8 India Market Size and Forecast, by Stage
      • 17.4.10.9 India Market Size and Forecast, by Services
      • 17.4.10.10 India Market Size and Forecast, by Device
      • 17.4.10.11 Local Competition Analysis
      • 17.4.10.12 Local Market Analysis
    • 17.4.1 Japan
      • 17.4.11.1 Japan Market Size and Forecast, by Type
      • 17.4.11.2 Japan Market Size and Forecast, by Product
      • 17.4.11.3 Japan Market Size and Forecast, by Application
      • 17.4.11.4 Japan Market Size and Forecast, by End User
      • 17.4.11.5 Japan Market Size and Forecast, by Technology
      • 17.4.11.6 Japan Market Size and Forecast, by Process
      • 17.4.11.7 Japan Market Size and Forecast, by Component
      • 17.4.11.8 Japan Market Size and Forecast, by Stage
      • 17.4.11.9 Japan Market Size and Forecast, by Services
      • 17.4.11.10 Japan Market Size and Forecast, by Device
      • 17.4.11.11 Local Competition Analysis
      • 17.4.11.12 Local Market Analysis
    • 17.4.1 South Korea
      • 17.4.12.1 South Korea Market Size and Forecast, by Type
      • 17.4.12.2 South Korea Market Size and Forecast, by Product
      • 17.4.12.3 South Korea Market Size and Forecast, by Application
      • 17.4.12.4 South Korea Market Size and Forecast, by End User
      • 17.4.12.5 South Korea Market Size and Forecast, by Technology
      • 17.4.12.6 South Korea Market Size and Forecast, by Process
      • 17.4.12.7 South Korea Market Size and Forecast, by Component
      • 17.4.12.8 South Korea Market Size and Forecast, by Stage
      • 17.4.12.9 South Korea Market Size and Forecast, by Services
      • 17.4.12.10 South Korea Market Size and Forecast, by Device
      • 17.4.12.11 Local Competition Analysis
      • 17.4.12.12 Local Market Analysis
    • 17.4.1 Australia
      • 17.4.13.1 Australia Market Size and Forecast, by Type
      • 17.4.13.2 Australia Market Size and Forecast, by Product
      • 17.4.13.3 Australia Market Size and Forecast, by Application
      • 17.4.13.4 Australia Market Size and Forecast, by End User
      • 17.4.13.5 Australia Market Size and Forecast, by Technology
      • 17.4.13.6 Australia Market Size and Forecast, by Process
      • 17.4.13.7 Australia Market Size and Forecast, by Component
      • 17.4.13.8 Australia Market Size and Forecast, by Stage
      • 17.4.13.9 Australia Market Size and Forecast, by Services
      • 17.4.13.10 Australia Market Size and Forecast, by Device
      • 17.4.13.11 Local Competition Analysis
      • 17.4.13.12 Local Market Analysis
    • 17.4.1 Singapore
      • 17.4.14.1 Singapore Market Size and Forecast, by Type
      • 17.4.14.2 Singapore Market Size and Forecast, by Product
      • 17.4.14.3 Singapore Market Size and Forecast, by Application
      • 17.4.14.4 Singapore Market Size and Forecast, by End User
      • 17.4.14.5 Singapore Market Size and Forecast, by Technology
      • 17.4.14.6 Singapore Market Size and Forecast, by Process
      • 17.4.14.7 Singapore Market Size and Forecast, by Component
      • 17.4.14.8 Singapore Market Size and Forecast, by Stage
      • 17.4.14.9 Singapore Market Size and Forecast, by Services
      • 17.4.14.10 Singapore Market Size and Forecast, by Device
      • 17.4.14.11 Local Competition Analysis
      • 17.4.14.12 Local Market Analysis
    • 17.4.1 Indonesia
      • 17.4.15.1 Indonesia Market Size and Forecast, by Type
      • 17.4.15.2 Indonesia Market Size and Forecast, by Product
      • 17.4.15.3 Indonesia Market Size and Forecast, by Application
      • 17.4.15.4 Indonesia Market Size and Forecast, by End User
      • 17.4.15.5 Indonesia Market Size and Forecast, by Technology
      • 17.4.15.6 Indonesia Market Size and Forecast, by Process
      • 17.4.15.7 Indonesia Market Size and Forecast, by Component
      • 17.4.15.8 Indonesia Market Size and Forecast, by Stage
      • 17.4.15.9 Indonesia Market Size and Forecast, by Services
      • 17.4.15.10 Indonesia Market Size and Forecast, by Device
      • 17.4.15.11 Local Competition Analysis
      • 17.4.15.12 Local Market Analysis
    • 17.4.1 Taiwan
      • 17.4.16.1 Taiwan Market Size and Forecast, by Type
      • 17.4.16.2 Taiwan Market Size and Forecast, by Product
      • 17.4.16.3 Taiwan Market Size and Forecast, by Application
      • 17.4.16.4 Taiwan Market Size and Forecast, by End User
      • 17.4.16.5 Taiwan Market Size and Forecast, by Technology
      • 17.4.16.6 Taiwan Market Size and Forecast, by Process
      • 17.4.16.7 Taiwan Market Size and Forecast, by Component
      • 17.4.16.8 Taiwan Market Size and Forecast, by Stage
      • 17.4.16.9 Taiwan Market Size and Forecast, by Services
      • 17.4.16.10 Taiwan Market Size and Forecast, by Device
      • 17.4.16.11 Local Competition Analysis
      • 17.4.16.12 Local Market Analysis
    • 17.4.1 Malaysia
      • 17.4.17.1 Malaysia Market Size and Forecast, by Type
      • 17.4.17.2 Malaysia Market Size and Forecast, by Product
      • 17.4.17.3 Malaysia Market Size and Forecast, by Application
      • 17.4.17.4 Malaysia Market Size and Forecast, by End User
      • 17.4.17.5 Malaysia Market Size and Forecast, by Technology
      • 17.4.17.6 Malaysia Market Size and Forecast, by Process
      • 17.4.17.7 Malaysia Market Size and Forecast, by Component
      • 17.4.17.8 Malaysia Market Size and Forecast, by Stage
      • 17.4.17.9 Malaysia Market Size and Forecast, by Services
      • 17.4.17.10 Malaysia Market Size and Forecast, by Device
      • 17.4.17.11 Local Competition Analysis
      • 17.4.17.12 Local Market Analysis
    • 17.4.1 Rest of Asia-Pacific
      • 17.4.18.1 Rest of Asia-Pacific Market Size and Forecast, by Type
      • 17.4.18.2 Rest of Asia-Pacific Market Size and Forecast, by Product
      • 17.4.18.3 Rest of Asia-Pacific Market Size and Forecast, by Application
      • 17.4.18.4 Rest of Asia-Pacific Market Size and Forecast, by End User
      • 17.4.18.5 Rest of Asia-Pacific Market Size and Forecast, by Technology
      • 17.4.18.6 Rest of Asia-Pacific Market Size and Forecast, by Process
      • 17.4.18.7 Rest of Asia-Pacific Market Size and Forecast, by Component
      • 17.4.18.8 Rest of Asia-Pacific Market Size and Forecast, by Stage
      • 17.4.18.9 Rest of Asia-Pacific Market Size and Forecast, by Services
      • 17.4.18.10 Rest of Asia-Pacific Market Size and Forecast, by Device
      • 17.4.18.11 Local Competition Analysis
      • 17.4.18.12 Local Market Analysis
  • 17.1 Latin America
    • 17.5.1 Key Market Trends and Opportunities
    • 17.5.2 Latin America Market Size and Forecast, by Type
    • 17.5.3 Latin America Market Size and Forecast, by Product
    • 17.5.4 Latin America Market Size and Forecast, by Application
    • 17.5.5 Latin America Market Size and Forecast, by End User
    • 17.5.6 Latin America Market Size and Forecast, by Technology
    • 17.5.7 Latin America Market Size and Forecast, by Process
    • 17.5.8 Latin America Market Size and Forecast, by Component
    • 17.5.9 Latin America Market Size and Forecast, by Stage
    • 17.5.10 Latin America Market Size and Forecast, by Services
    • 17.5.11 Latin America Market Size and Forecast, by Device
    • 17.5.12 Latin America Market Size and Forecast, by Country
    • 17.5.13 Brazil
      • 17.5.9.1 Brazil Market Size and Forecast, by Type
      • 17.5.9.2 Brazil Market Size and Forecast, by Product
      • 17.5.9.3 Brazil Market Size and Forecast, by Application
      • 17.5.9.4 Brazil Market Size and Forecast, by End User
      • 17.5.9.5 Brazil Market Size and Forecast, by Technology
      • 17.5.9.6 Brazil Market Size and Forecast, by Process
      • 17.5.9.7 Brazil Market Size and Forecast, by Component
      • 17.5.9.8 Brazil Market Size and Forecast, by Stage
      • 17.5.9.9 Brazil Market Size and Forecast, by Services
      • 17.5.9.10 Brazil Market Size and Forecast, by Device
      • 17.5.9.11 Local Competition Analysis
      • 17.5.9.12 Local Market Analysis
    • 17.5.1 Mexico
      • 17.5.10.1 Mexico Market Size and Forecast, by Type
      • 17.5.10.2 Mexico Market Size and Forecast, by Product
      • 17.5.10.3 Mexico Market Size and Forecast, by Application
      • 17.5.10.4 Mexico Market Size and Forecast, by End User
      • 17.5.10.5 Mexico Market Size and Forecast, by Technology
      • 17.5.10.6 Mexico Market Size and Forecast, by Process
      • 17.5.10.7 Mexico Market Size and Forecast, by Component
      • 17.5.10.8 Mexico Market Size and Forecast, by Stage
      • 17.5.10.9 Mexico Market Size and Forecast, by Services
      • 17.5.10.10 Mexico Market Size and Forecast, by Device
      • 17.5.10.11 Local Competition Analysis
      • 17.5.10.12 Local Market Analysis
    • 17.5.1 Argentina
      • 17.5.11.1 Argentina Market Size and Forecast, by Type
      • 17.5.11.2 Argentina Market Size and Forecast, by Product
      • 17.5.11.3 Argentina Market Size and Forecast, by Application
      • 17.5.11.4 Argentina Market Size and Forecast, by End User
      • 17.5.11.5 Argentina Market Size and Forecast, by Technology
      • 17.5.11.6 Argentina Market Size and Forecast, by Process
      • 17.5.11.7 Argentina Market Size and Forecast, by Component
      • 17.5.11.8 Argentina Market Size and Forecast, by Stage
      • 17.5.11.9 Argentina Market Size and Forecast, by Services
      • 17.5.11.10 Argentina Market Size and Forecast, by Device
      • 17.5.11.11 Local Competition Analysis
      • 17.5.11.12 Local Market Analysis
    • 17.5.1 Rest of Latin America
      • 17.5.12.1 Rest of Latin America Market Size and Forecast, by Type
      • 17.5.12.2 Rest of Latin America Market Size and Forecast, by Product
      • 17.5.12.3 Rest of Latin America Market Size and Forecast, by Application
      • 17.5.12.4 Rest of Latin America Market Size and Forecast, by End User
      • 17.5.12.5 Rest of Latin America Market Size and Forecast, by Technology
      • 17.5.12.6 Rest of Latin America Market Size and Forecast, by Process
      • 17.5.12.7 Rest of Latin America Market Size and Forecast, by Component
      • 17.5.12.8 Rest of Latin America Market Size and Forecast, by Stage
      • 17.5.12.9 Rest of Latin America Market Size and Forecast, by Services
      • 17.5.12.10 Rest of Latin America Market Size and Forecast, by Device
      • 17.5.12.11 Local Competition Analysis
      • 17.5.12.12 Local Market Analysis
  • 17.1 Middle East and Africa
    • 17.6.1 Key Market Trends and Opportunities
    • 17.6.2 Middle East and Africa Market Size and Forecast, by Type
    • 17.6.3 Middle East and Africa Market Size and Forecast, by Product
    • 17.6.4 Middle East and Africa Market Size and Forecast, by Application
    • 17.6.5 Middle East and Africa Market Size and Forecast, by End User
    • 17.6.6 Middle East and Africa Market Size and Forecast, by Technology
    • 17.6.7 Middle East and Africa Market Size and Forecast, by Process
    • 17.6.8 Middle East and Africa Market Size and Forecast, by Component
    • 17.6.9 Middle East and Africa Market Size and Forecast, by Stage
    • 17.6.10 Middle East and Africa Market Size and Forecast, by Services
    • 17.6.11 Middle East and Africa Market Size and Forecast, by Device
    • 17.6.12 Middle East and Africa Market Size and Forecast, by Country
    • 17.6.13 Saudi Arabia
      • 17.6.9.1 Saudi Arabia Market Size and Forecast, by Type
      • 17.6.9.2 Saudi Arabia Market Size and Forecast, by Product
      • 17.6.9.3 Saudi Arabia Market Size and Forecast, by Application
      • 17.6.9.4 Saudi Arabia Market Size and Forecast, by End User
      • 17.6.9.5 Saudi Arabia Market Size and Forecast, by Technology
      • 17.6.9.6 Saudi Arabia Market Size and Forecast, by Process
      • 17.6.9.7 Saudi Arabia Market Size and Forecast, by Component
      • 17.6.9.8 Saudi Arabia Market Size and Forecast, by Stage
      • 17.6.9.9 Saudi Arabia Market Size and Forecast, by Services
      • 17.6.9.10 Saudi Arabia Market Size and Forecast, by Device
      • 17.6.9.11 Local Competition Analysis
      • 17.6.9.12 Local Market Analysis
    • 17.6.1 UAE
      • 17.6.10.1 UAE Market Size and Forecast, by Type
      • 17.6.10.2 UAE Market Size and Forecast, by Product
      • 17.6.10.3 UAE Market Size and Forecast, by Application
      • 17.6.10.4 UAE Market Size and Forecast, by End User
      • 17.6.10.5 UAE Market Size and Forecast, by Technology
      • 17.6.10.6 UAE Market Size and Forecast, by Process
      • 17.6.10.7 UAE Market Size and Forecast, by Component
      • 17.6.10.8 UAE Market Size and Forecast, by Stage
      • 17.6.10.9 UAE Market Size and Forecast, by Services
      • 17.6.10.10 UAE Market Size and Forecast, by Device
      • 17.6.10.11 Local Competition Analysis
      • 17.6.10.12 Local Market Analysis
    • 17.6.1 South Africa
      • 17.6.11.1 South Africa Market Size and Forecast, by Type
      • 17.6.11.2 South Africa Market Size and Forecast, by Product
      • 17.6.11.3 South Africa Market Size and Forecast, by Application
      • 17.6.11.4 South Africa Market Size and Forecast, by End User
      • 17.6.11.5 South Africa Market Size and Forecast, by Technology
      • 17.6.11.6 South Africa Market Size and Forecast, by Process
      • 17.6.11.7 South Africa Market Size and Forecast, by Component
      • 17.6.11.8 South Africa Market Size and Forecast, by Stage
      • 17.6.11.9 South Africa Market Size and Forecast, by Services
      • 17.6.11.10 South Africa Market Size and Forecast, by Device
      • 17.6.11.11 Local Competition Analysis
      • 17.6.11.12 Local Market Analysis
    • 17.6.1 Rest of MEA
      • 17.6.12.1 Rest of MEA Market Size and Forecast, by Type
      • 17.6.12.2 Rest of MEA Market Size and Forecast, by Product
      • 17.6.12.3 Rest of MEA Market Size and Forecast, by Application
      • 17.6.12.4 Rest of MEA Market Size and Forecast, by End User
      • 17.6.12.5 Rest of MEA Market Size and Forecast, by Technology
      • 17.6.12.6 Rest of MEA Market Size and Forecast, by Process
      • 17.6.12.7 Rest of MEA Market Size and Forecast, by Component
      • 17.6.12.8 Rest of MEA Market Size and Forecast, by Stage
      • 17.6.12.9 Rest of MEA Market Size and Forecast, by Services
      • 17.6.12.10 Rest of MEA Market Size and Forecast, by Device
      • 17.6.12.11 Local Competition Analysis
      • 17.6.12.12 Local Market Analysis

18: Competitive Landscape

  • 18.1 Overview
  • 18.2 Market Share Analysis
  • 18.3 Key Player Positioning
  • 18.4 Competitive Leadership Mapping
    • 18.4.1 Star Players
    • 18.4.2 Innovators
    • 18.4.3 Emerging Players
  • 18.5 Vendor Benchmarking
  • 18.6 Developmental Strategy Benchmarking
    • 18.6.1 New Product Developments
    • 18.6.2 Product Launches
    • 18.6.3 Business Expansions
    • 18.6.4 Partnerships, Joint Ventures, and Collaborations
    • 18.6.5 Mergers and Acquisitions

19: Company Profiles

  • 19.1 Alvotech
    • 19.1.1 Company Overview
    • 19.1.2 Company Snapshot
    • 19.1.3 Business Segments
    • 19.1.4 Business Performance
    • 19.1.5 Product Offerings
    • 19.1.6 Key Developmental Strategies
    • 19.1.7 SWOT Analysis
  • 19.2 Coherus BioSciences
    • 19.2.1 Company Overview
    • 19.2.2 Company Snapshot
    • 19.2.3 Business Segments
    • 19.2.4 Business Performance
    • 19.2.5 Product Offerings
    • 19.2.6 Key Developmental Strategies
    • 19.2.7 SWOT Analysis
  • 19.3 Amgen
    • 19.3.1 Company Overview
    • 19.3.2 Company Snapshot
    • 19.3.3 Business Segments
    • 19.3.4 Business Performance
    • 19.3.5 Product Offerings
    • 19.3.6 Key Developmental Strategies
    • 19.3.7 SWOT Analysis
  • 19.4 Samsung Bioepis
    • 19.4.1 Company Overview
    • 19.4.2 Company Snapshot
    • 19.4.3 Business Segments
    • 19.4.4 Business Performance
    • 19.4.5 Product Offerings
    • 19.4.6 Key Developmental Strategies
    • 19.4.7 SWOT Analysis
  • 19.5 Celltrion
    • 19.5.1 Company Overview
    • 19.5.2 Company Snapshot
    • 19.5.3 Business Segments
    • 19.5.4 Business Performance
    • 19.5.5 Product Offerings
    • 19.5.6 Key Developmental Strategies
    • 19.5.7 SWOT Analysis
  • 19.6 Biocon
    • 19.6.1 Company Overview
    • 19.6.2 Company Snapshot
    • 19.6.3 Business Segments
    • 19.6.4 Business Performance
    • 19.6.5 Product Offerings
    • 19.6.6 Key Developmental Strategies
    • 19.6.7 SWOT Analysis
  • 19.7 Sandoz
    • 19.7.1 Company Overview
    • 19.7.2 Company Snapshot
    • 19.7.3 Business Segments
    • 19.7.4 Business Performance
    • 19.7.5 Product Offerings
    • 19.7.6 Key Developmental Strategies
    • 19.7.7 SWOT Analysis
  • 19.8 Mylan
    • 19.8.1 Company Overview
    • 19.8.2 Company Snapshot
    • 19.8.3 Business Segments
    • 19.8.4 Business Performance
    • 19.8.5 Product Offerings
    • 19.8.6 Key Developmental Strategies
    • 19.8.7 SWOT Analysis
  • 19.9 Fresenius Kabi
    • 19.9.1 Company Overview
    • 19.9.2 Company Snapshot
    • 19.9.3 Business Segments
    • 19.9.4 Business Performance
    • 19.9.5 Product Offerings
    • 19.9.6 Key Developmental Strategies
    • 19.9.7 SWOT Analysis
  • 19.10 Stada Arzneimittel
    • 19.10.1 Company Overview
    • 19.10.2 Company Snapshot
    • 19.10.3 Business Segments
    • 19.10.4 Business Performance
    • 19.10.5 Product Offerings
    • 19.10.6 Key Developmental Strategies
    • 19.10.7 SWOT Analysis
  • 19.11 Dr Reddy's Laboratories
    • 19.11.1 Company Overview
    • 19.11.2 Company Snapshot
    • 19.11.3 Business Segments
    • 19.11.4 Business Performance
    • 19.11.5 Product Offerings
    • 19.11.6 Key Developmental Strategies
    • 19.11.7 SWOT Analysis
  • 19.12 Lupin
    • 19.12.1 Company Overview
    • 19.12.2 Company Snapshot
    • 19.12.3 Business Segments
    • 19.12.4 Business Performance
    • 19.12.5 Product Offerings
    • 19.12.6 Key Developmental Strategies
    • 19.12.7 SWOT Analysis
  • 19.13 Hikma Pharmaceuticals
    • 19.13.1 Company Overview
    • 19.13.2 Company Snapshot
    • 19.13.3 Business Segments
    • 19.13.4 Business Performance
    • 19.13.5 Product Offerings
    • 19.13.6 Key Developmental Strategies
    • 19.13.7 SWOT Analysis
  • 19.14 Apotex
    • 19.14.1 Company Overview
    • 19.14.2 Company Snapshot
    • 19.14.3 Business Segments
    • 19.14.4 Business Performance
    • 19.14.5 Product Offerings
    • 19.14.6 Key Developmental Strategies
    • 19.14.7 SWOT Analysis
  • 19.15 Teva Pharmaceutical Industries
    • 19.15.1 Company Overview
    • 19.15.2 Company Snapshot
    • 19.15.3 Business Segments
    • 19.15.4 Business Performance
    • 19.15.5 Product Offerings
    • 19.15.6 Key Developmental Strategies
    • 19.15.7 SWOT Analysis
  • 19.16 Zydus Cadila
    • 19.16.1 Company Overview
    • 19.16.2 Company Snapshot
    • 19.16.3 Business Segments
    • 19.16.4 Business Performance
    • 19.16.5 Product Offerings
    • 19.16.6 Key Developmental Strategies
    • 19.16.7 SWOT Analysis
  • 19.17 Torrent Pharmaceuticals
    • 19.17.1 Company Overview
    • 19.17.2 Company Snapshot
    • 19.17.3 Business Segments
    • 19.17.4 Business Performance
    • 19.17.5 Product Offerings
    • 19.17.6 Key Developmental Strategies
    • 19.17.7 SWOT Analysis
  • 19.18 Cadila Healthcare
    • 19.18.1 Company Overview
    • 19.18.2 Company Snapshot
    • 19.18.3 Business Segments
    • 19.18.4 Business Performance
    • 19.18.5 Product Offerings
    • 19.18.6 Key Developmental Strategies
    • 19.18.7 SWOT Analysis
  • 19.19 Alkem Laboratories
    • 19.19.1 Company Overview
    • 19.19.2 Company Snapshot
    • 19.19.3 Business Segments
    • 19.19.4 Business Performance
    • 19.19.5 Product Offerings
    • 19.19.6 Key Developmental Strategies
    • 19.19.7 SWOT Analysis
  • 19.20 Gedeon Richter
    • 19.20.1 Company Overview
    • 19.20.2 Company Snapshot
    • 19.20.3 Business Segments
    • 19.20.4 Business Performance
    • 19.20.5 Product Offerings
    • 19.20.6 Key Developmental Strategies
    • 19.20.7 SWOT Analysis